CureVac N.V. (FRA:5CV)
4.350
-0.114 (-2.55%)
Dec 2, 2025, 12:11 PM CET
CureVac Employees
As of December 31, 2024, CureVac had 983 total employees, including 825 full-time and 158 part-time employees. The number of employees decreased by 189 or -16.13% compared to the previous year.
Employees
983
Change (1Y)
-189
Growth (1Y)
-16.13%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
1.01B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 983 | -189 | -16.13% |
| Dec 31, 2023 | 1,172 | 123 | 11.73% |
| Dec 31, 2022 | 1,049 | 165 | 18.67% |
| Dec 31, 2021 | 884 | 330 | 59.57% |
| Dec 31, 2020 | 554 | 100 | 22.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,730 |
CureVac News
- 4 days ago - CureVac N.V. (CVAC) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 5 days ago - BioNTech (BNTX) Moves Forward with CureVac Acquisition - GuruFocus
- 6 days ago - BioNTech (BNTX) Advances with Exchange Offer for CureVac Shares - GuruFocus
- 6 days ago - BioNTech’s exchange offer for German mRNA vaccine peer CureVac set to expire Dec. 3 - Seeking Alpha
- 6 days ago - CureVac Announces Voting Results of Extraordinary General Meeting - Accesswire
- 6 days ago - CureVac Reveals Key Voting Outcomes from Extraordinary Shareholder Meeting - Wallstreet:Online
- 6 days ago - EQS-News: CureVac Announces Voting Results of Extraordinary General Meeting • news - Onvista
- 7 days ago - Company News for Nov 25, 2025 - Nasdaq